Furthermore, steps were taken to close down the operating theatres used to treat the patients who had complications, as the germ in question could have spread inside the theatres.
The National Eye Hospital’s spokesperson told News 1st that surgeries will resume once the operating rooms have been sterilised.
Patients at the Batticaloa Teaching Hospital have also reported a similar complication.
According to a hospital spokesperson, an investigation is underway.
Notably, both of these hospitals had used Prednisolone eye drops that had been imported from India.
Dr. D. R. K. Herath of the Ministry of Health’s Medical Supplies Division (MSD) told News 1st that laboratory test reports on the Indian drug have yet to be completed.
After complications were reported following its use, Sri Lanka’s Health Ministry informed all hospital directors to immediately suspend the use of Prednisolone eye drops imported from India.
The delivery of Prednisolone eye drops to hospitals has also been halted, according to the Health Ministry’s Medical Supplies Division.
According to a spokesperson for the National Eye Hospital, problems with the Prednisolone eye drops arose after three patients who underwent surgery experienced complications.
According to the spokesperson, all equipment used for the surgeries was directed for testing and inspections.
According to reports obtained 48 hours after the surgeries, it was discovered that one of the medications in question was to blame for the complications.
Furthermore, steps were taken to close down the operating theatres used to treat the patients who had complications, as the germ in question could have spread inside the theatres.
The National Eye Hospital’s spokesperson told News 1st that surgeries will resume once the operating rooms have been sterilised.
Patients at the Batticaloa Teaching Hospital have also reported a similar complication.
According to a hospital spokesperson, an investigation is underway.
Notably, both of these hospitals had used Prednisolone eye drops that had been imported from India.
Dr. D. R. K. Herath of the Ministry of Health’s Medical Supplies Division (MSD) told News 1st that laboratory test reports on the Indian drug have yet to be completed.
